< Back to previous page
Researcher
Dirk De Ruysscher
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Jul 2012 → 31 Dec 2018
Projects
1 - 7 of 7
- Quest for tissue biomarkers for immune therapy in non-small cell lung cancerFrom1 Oct 2014 → 30 Sep 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Surgical Mediastinal Staging and Minimally Invasive Resection in the Treatment of Non-Small Cell Lung Cancer.From1 Sep 2014 → 23 Jan 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- High precision small animal radiotherapy platform.From19 May 2014 → 31 Dec 2018Funding: Hercules - Small and Medium size research infrastructure
- Improvement of memory function after Prophylactic Cranial Irradiation (PCI) by avoidance of the hippocampus: a randomized phase III study in small cell lung cancer patients.From1 Jan 2014 → 31 Dec 2017Funding: Private funding of national origin - undefined
- Improvement of memory function after Prophylactic Cranial Irradiation (PCI) by avoidance of the hippocampus: A randomized phase III study in small cell lung cancer patients.From1 Dec 2013 → 30 Nov 2017Funding: IWT - TBM (Applied Biomedical Research)
- Image-based quantification of radiation-induced lung damageFrom1 Oct 2013 → 19 Jan 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors.From27 Sep 2013 → 30 Sep 2018Funding: Health
Publications
1 - 10 of 270
- The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset(2021)
Authors: Dirk De Ruysscher
Pages: 32 - 38 - External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort(2020)
Authors: Dirk De Ruysscher
- Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study(2020)
Authors: Dirk De Ruysscher
Pages: 65 - 71 - Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer(2020)
Authors: Dirk De Ruysscher, Kristiaan Nackaerts
Pages: 41 - 49 - Imaging of regional ventilation: Is CT ventilation imaging the answer? A systematic review of the validation data(2019)
Authors: Dirk De Ruysscher
Pages: 175 - 185 - Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial(2019)
Authors: Maarten Lambrecht, Johan Vansteenkiste, Dirk De Ruysscher
Pages: 83 - 87 - Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older(2019)
Authors: Elisabeth Driessen, Deniece Detillon, Gerbern Bootsma, Dirk De Ruysscher, Eelco Veen, Mieke Aarts, Maryska Janssen-Heijnen
Pages: 547 - 554 - Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study(2019)
Authors: Dirk De Ruysscher, Angela van Baardwijk, Rinus Wanders, Lizza E Hendriks, Bait Reymen, Wouter van Empt, Michel C Ollers, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, et al.
Pages: 141 - 146 - Quality of Life After Stereotactic Radiotherapy for Early-Stage Lung Cancer: Mission Accomplished?(2019)
Authors: Dirk De Ruysscher
Pages: 326 - 327 - Radiotherapy toxicity(2019)
Authors: Dirk De Ruysscher, Gabriele Niedermann, Neil G Burnet, Shankar Siva, Anne WM Lee, Fiona Hegi-Johnson